Haemonetics (HAE) Free Cash Flow (2009 - 2026)

Haemonetics' Free Cash Flow history runs 18 years deep, the most recent figure standing at $53.3 million for Q1 2026.

• On a quarterly basis, Free Cash Flow fell 47.2% year-over-year to $53.3 million in Q1 2026; TTM through Mar 2026 was $260.4 million, a 82.83% increase from a year earlier, with the FY2026 full-year figure at $260.4 million, up 82.83% from the prior year.
• Free Cash Flow declined to $53.3 million in Q1 2026 per HAE's latest filing, from $87.2 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $106.3 million in Q3 2025 and bottomed at -$33.1 million in Q2 2024.
• The 5-year median for Free Cash Flow is $37.6 million (2022), against an average of $38.7 million.
• Biggest YoY gain for Free Cash Flow was 526.93% in 2024; the steepest drop was 390.02% in 2024.
• Year by year, Free Cash Flow stood at $47.6 million in 2022, then plunged by 131.93% to -$15.2 million in 2023, then soared by 331.92% to $35.2 million in 2024, then soared by 147.63% to $87.2 million in 2025, then plunged by 38.91% to $53.3 million in 2026.
• Per Business Quant, the three latest HAE Free Cash Flow figures stand at $53.3 million (Q1 2026), $87.2 million (Q4 2025), and $106.3 million (Q3 2025).